Perez EA - Search Results

1

Effects of Age and Immune Landscape on Outcome in HER2-Positive Breast Cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) Trials.

Chumsri S, Serie DJ, Li Z, Pogue-Geile KL, Soyano-Muller AE, Mashadi-Hossein A, Warren S, Lou Y, Colon-Otero G, Knutson KL, Perez EA, Moreno-Aspitia A, Thompson EA. Chumsri S, et al. Among authors: perez ea. Clin Cancer Res. 2019 Jul 15;25(14):4422-4430. doi: 10.1158/1078-0432.CCR-18-2206. Epub 2019 Feb 26. Clin Cancer Res. 2019. PMID: 30808774 Free PMC article. Clinical Trial.

2

Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831.

Roche PC, Suman VJ, Jenkins RB, Davidson NE, Martino S, Kaufman PA, Addo FK, Murphy B, Ingle JN, Perez EA. Roche PC, et al. Among authors: perez ea. J Natl Cancer Inst. 2002 Jun 5;94(11):855-7. doi: 10.1093/jnci/94.11.855. J Natl Cancer Inst. 2002. PMID: 12048274

3

Adjuvant therapy approaches to breast cancer: should taxanes be incorporated?

Perez EA. Perez EA. Curr Oncol Rep. 2003 Jan;5(1):66-71. doi: 10.1007/s11912-003-0089-4. Curr Oncol Rep. 2003. PMID: 12493153 Review.

4

Weekly carboplatin and paclitaxel in elderly non-small-cell lung cancer patients (>or=65 years of age): a phase II North Central Cancer Treatment Group study.

Jatoi A, Stella PJ, Hillman S, Mailliard JA, Vanone S, Perez EA, Cannon MW, Geyer S, Wiesenfeld M, Jett JR. Jatoi A, et al. Among authors: perez ea. Am J Clin Oncol. 2003 Oct;26(5):441-7. doi: 10.1097/01.coc.0000027460.53907.38. Am J Clin Oncol. 2003. PMID: 14528068 Clinical Trial.

5

Gemcitabine and platinum combinations in patients with breast cancer previously treated with anthracyclines and/or taxanes.

Perez EA. Perez EA. Clin Breast Cancer. 2004 Jan;4 Suppl 3:S113-6. doi: 10.3816/cbc.2004.s.004. Clin Breast Cancer. 2004. PMID: 14754468 Review.

6

Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial.

Perez EA, Suman VJ, Davidson NE, Kaufman PA, Martino S, Dakhil SR, Ingle JN, Rodeheffer RJ, Gersh BJ, Jaffe AS. Perez EA, et al. J Clin Oncol. 2004 Sep 15;22(18):3700-4. doi: 10.1200/JCO.2004.03.516. J Clin Oncol. 2004. PMID: 15365066 Clinical Trial.

7

Carboplatin in combination therapy for metastatic breast cancer.

Perez EA. Perez EA. Oncologist. 2004;9(5):518-27. doi: 10.1634/theoncologist.9-5-518. Oncologist. 2004. PMID: 15477636 Free article. Review.

8

Anthracycline vs nonanthracycline adjuvant therapy for breast cancer.

Tack DK, Palmieri FM, Perez EA. Tack DK, et al. Among authors: perez ea. Oncology (Williston Park). 2004 Oct;18(11):1367-76; discussion 1378, 1381. Oncology (Williston Park). 2004. PMID: 15609467 Free article. Review.

9

Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer: a North Central Cancer Treatment Group Trial.

Burch PA, Mailliard JA, Hillman DW, Perez EA, Krook JE, Rowland KM, Veeder MH, Cannon MW, Ingle JN. Burch PA, et al. Among authors: perez ea. Am J Clin Oncol. 2005 Apr;28(2):195-200. doi: 10.1097/01.coc.0000144815.54746.d0. Am J Clin Oncol. 2005. PMID: 15803016 Clinical Trial.

10

Serum soluble epidermal growth factor receptor concentrations decrease in postmenopausal metastatic breast cancer patients treated with letrozole.

Lafky JM, Baron AT, Cora EM, Hillman DW, Suman VJ, Perez EA, Ingle JN, Maihle NJ. Lafky JM, et al. Among authors: perez ea. Cancer Res. 2005 Apr 15;65(8):3059-62. doi: 10.1158/0008-5472.CAN-05-0067. Cancer Res. 2005. PMID: 15833834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

627 results

Search Page

Filters